Abstract
Objective: Patients with uterine carcinosarcoma (UCS) are at a high risk of local and distant recurrence and have a poor prognosis in the recurrent setting. Our objective was to determine whether lymph node dissection (LND) at the time of primary surgery has either prognostic or therapeutic value for patients with apparent stage I UCS.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
